US states move for final nod on Bausch, Lannett settlements in generic drug antitrust case
MLex Summary: US states asked a federal judge to approve their settlements with Bausch Health and Lannett Company to resolve allegations that they conspired to artificially inflate and manipulate prices for...To view the full article, register now.
Already a subscriber? Click here to view full article